A recent OpenAI experiment revealed how fast GenAI is advancing, and why doctors and patients should rethink what’s technologically possible in medicine.
A public health expert explains public health concerns amid the CDC’s decision not to count two measles deaths in Pennsylvania.
An increasing number of industry analysts say costs are under control for the likes of CVS Health, Centene, Cigna, Elevance Health, Humana, UnitedHealth Group and others.
A new generation of AI startups is emerging with powerful tools that could reshape how doctors work, make decisions, and ultimately deliver patient care.
A doctor breaks down what you need to know about rabies and how to stay safe amid the CDC new advisory on increased exposures.
A new two-step method makes more uniform antibody-drug conjugates by attaching cancer drugs at a precise antibody site, simplifying targeted cancer drug development.
On August 20, Kazakhstan’s Elena Rybakina had to drop out of the Cincinnati Open with a left ankle injury. But now she’s made it to the 2026 U.S. Open singles final.
A strong emergency plan does more than prepare for one scenario. Learn how families can build backup plans for communication, transportation, medical needs and care.
FDA-approved daraxonrasib targets RAS in metastatic pancreatic cancer, doubling median survival versus chemotherapy and delivering a long-awaited treatment advance.
Why calling OBBBA a “$1 trillion Medicaid cut” misses the bigger story: spending still rises, while the law trims a rapidly growing baseline.